Atomic absorption spectrometry was used for red cell (MgRC) and plasma Mg (MgPL) measurement (rnEq/L) in 24 normal individuals (Nls), aged 42.16* 16 years, and 44 carefully selected consecutive patients (pts), aged 60.68 k 10 years with cor pulmonale. The results showed the following: (1) normal MgPL (1.69k 0.19) and MgRC (4.222 0.32) in Nls; (2) decreased MgpL (1.56f 0.23) and MgRC (2.85k0.54) in pts; (3) decreased FEV, percent (37.56k13.1) in pts; (4) increased RVIDd (1.73k0.31 cm/ml) of the pts by M-mode echo; and (5) 
M
agnesium is the second most abundant intracellular cation in the body,' next to potassium, while less than 1 percent of the total body magnesium is found in the extracellular compartment. Thus, plasma levels alone may not reflect tissue levels, which explains why the plasma magnesium level is not indicative of the intracellular magnesium content. Thus, the physician should always measure the magnesium content of blood cells (erythrocytes, lymphocytes) or the skeletal muscle cells.2 Many studies suggest an important role of magnesium in various clinical syndromes and diseases, like hypokalemia and hypocalcemia, respiratory muscle weakness, cardiac arrhythmias, arterial hypertension, or ischemic heart d i~e a s e .~ On the other hand, magnesium deficits have been reported in many accompanied by a variety of structural and functional disturbance^^.^ or may occur as a consequence of drug therapy, such as after aminoglycosidesR and digoxing therapy. Despite the known frequency of this metabolic disorder, little is known about the prevalence and clinical implications of hypomagnesemia in patients with chronic pulmonary disease and chronic cor pulmonale. This study aims to evaluate red cell and plasma Mg levels as well as its correlation with IVSTd=interventricular septa1 thickness in diastole; M =magnesium; MgPL = plasma magnesium; MgRC = red cei ma esium; Nls = normal individuals; RBBB = right bundle b r a n c r b l o c k ; RVH = right ventricular hypertrophy;
RVIDd=right ventricular internal diameter in diastole; RVWTd = right ventricular wall thickness in diastole.
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cardiopulmonary examinations in patients with cor pulmonale, which, to the best of our knowledge, has never been reported in the literature.
Subjects
Forty-four carefully selected consecutive patients, aged 60.68 + 10 years, admitted to the Aristotle University Cardiopulmonary Unit of the General Hospital "George Papanikolaou," were studied. All patients had long-term pulmonary disease and concomitant cor pulmonale m b l e 1). None of the patients was known to have hypomagnesemia or hypermagnesemia before hospital admission.
Design of Study
The following protocol was kept for all patients entering the study: demographic data (age, sex, and race), medication administered, and medical history were recorded. Patients with pulmonary disease exacerbation or right-sided heart failure were excluded from the study. AU patients studied were free of known medication causing renal loss of Mg1° for at least three days prior to hospital Table 3 ) were also recorded.
Definitions
In our laboratory, atomic absorption spectmphotometry was also used for red cell and plasma magnesium measurement in normal individuals (Nls), aged 42.16 k 16 years, who were defined as the contml group. Normal plasma and red cell magnesium concentrations were found to be 1.69k0.19 mEq/L and 4.2220.32 mEq/L, respectively. IIypomagnesemia was, therefore, defined as a plasma Mg level of 1.31 mEq/L or less and a red cell Mg level of 3.58 mEq/ L or less, while hypermagnesemia was defined as a value of 2.07 mEq/L and 4.86 mEq/L or more in plasma and red cells, respec tively.
Statistfed Analyses
Data were analyzed using ,yP tesing (fourfold table with Yates' correction), Pearson's product correlation ~uefficient, and Student's t testing for analysis of repetitive measurements. The difference between p u p s was determined by calculation of an analysis of variance (F test). The mean ( 2 SD) was determined for variables as indicated. Significance was defined as a p value of less than 0.05. All statistical analyses were performed with personal computer (Hyundai PC, using the Microstat INC. release 4, and Harvard Graphics statistical pmgram).
Of the 44 patients studied, red cell and plasma magnesium levels were 2.85 & 0.54 mEq/L and 1.5620.23 mEqL, respectively (Fig 1) . Using Student's t test, there was significant statistical difference All patients had chronic pulmonary disease with an FEV, percent = 37.56 2 13.1 of predicted. There was no significant statistical correlation between plasma magnesium levels and FEV, percent of the 44 patients studied (r = 0.17, p>0.05); however, significant statistical correlation was found between red cell Mg levels and FEV, percent of t h e patients ( r = 0 . 4 7 , 0.01>p>0.001) (Fig 2) . This significant correlation therefore suggests some bronchodilator action of Mg cations.
Twelve-lead ECG examination, performed in all patients mble 2), revealed normal ECG in 8144 patients (18. (Table  4) .
There was no difference between plasma Mg concentration of patients with normal and abnormal ECG (x2= 1.25, p>0.1), but the same statistical analysis for erythrocytes Mg concentration between those two groups revealed significant difference (x2=4.72, p<0.05). Futhermore, analysis of variance, using the 
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= Roe all mrgmlum cwmtrrtlon F test, performed among the three groups (7able 4), revealed significant difference for red cell Mg concentration (p<0.01), not existing for plasma magnesium concentration (p>0.05). In 39 of 44 patients, the echocardiographic examination by M mode was diagnostic for right ventricular dilatation ( Table 3 ). The imaging in five patients was impossible because of their hyperinflated lungs. The mean plasma and red cell Mg concentration of those 39 patients was 1.56+0.23 mEq/L and 2.8220.52 mEq/L, respectively. No correlation existed between plasma Mg concentration and right ventricular internal diameter in diastole (RVIDd), right ventricular wall thickness in diastole (RVWTd), and intraventricular septa1 thickness in diastole (IVSTd) (p>0.05) of the patients studied. Similarly, no correlation existed between red cell Mg concentration and RVWTd or IVSTd (p>0.05) of those patients. However, there was significant correlation between red cell M g levels and RVIDd (r = -0.43, p<0.01) (Fig 3) .
The high prevalence of red cell hypomagnesemia observed in the present study has never been reported previously in the literature, to our knowledge. Low muscle and serum magnesium levels, found in pulmonary ICU patients,I3 support our findings. Similarly, recent results presented by Dr. Hauser during the Third European Congress on Magnesium 1990L4 showed a statistically significant improvement in FEV, (p<O.O2) of 17 patients with confirmed bronchial asthma, treated with antiasthmatic therapy and Mg salts simultaneously; this was suggestive of the presence of hypomagnesemia. The association between intracellular hypomagnesemia and severe bronchial obstruction, therefore, suggests some bronchodilator action of magnesium cations and is, obviously, in strong relationship with Dr. Hauser's results. This important observation, promising new therapeutic devices, needs further investigation.
No correlation was found between plasma and red cell Mg levels in our patients. These data parallel a significant group of previous reports that suggest that intracellular and extracellular Mg concentrations can vary independently and a deficit in one may not be a c c o m p a n i e d b y a significant c h a n g e in t h e Since plasma magnesium levels have been poorly correlated with tissue magnesium levels in red cells, it is essential that the measurement of both the intracellr~lar and extracellular Mg should be determined simultaneously.
None of the known causes was an apparent precipitant for the development of hypomagnesemia in our patients; however, it is supposed that long-term therapy prior to the study, including diuretics, digoxin, P2-stimulants, and antibiotics, which produce renal loss of Mg2+, stress, inadequate intake because of extreme dyspnea and perhaps, aging, may cause an intracellular shift of magnesium.
It is noticeable that no correlation was found between magnesium deficiency and clinical signs or symptoms. This is in agreement with reports of Kingston et all7 and Zaloga. 15 We conclude that the physiologic effect of mild decreases in extracellular and the cellular effects of low intracellular magnesium concentrations require further study and understanding of Mg metabolism. However, the relationship between intracellular hypomagnesemia and ECG arrhythmias in patients with cor pulmonale secondary to chronic pulmonary disease would appear to be an important observation. Many studies report the arrhythmogenic effect of serum Mg deficiencylx.%' and it is well known that magnesium salts are frequently used for their antiarrhythmic and neuronal effects even in normomagnesemic patients. 15 The authors suggest that reversal of arrhythmias with magnesium administration might indicate tissue deficiency, but this has not been rigorously tested. The presence of significant correlation between red cell magnesium concentration and ECG arrhythmias in our patients suggests a better understanding of this phenomenon.
Furthermore, we identified for the first time the association of hypomagnesemia and right ventricular dilatation by M-mode echocardiography in patients with cor pulmonale. The usefulness of M-mode evaluation of the right side of the heart is limited, particularly in patients with chronic pulmonary disease and abnormalities of thoracic configuration or hyperinflated lungs.21 Despite these limitations, the M-mode echocardiography provides an excellent screening test for right ventricular dysfunction by depicting chamber size and wall thickness, so that other invasive diagnostic procedures are usually unnecessary.
Very recent experimental studies in rats indicate that Mg2+ treatment can prevent development of experimental, chemically induced, pulmonary hypert e n~i o n .~.~ These reports are in agreement with the negative correlation between intracellular Mg levels and the size of the right chamber of the heart of our patients.
We speculate that magnesium deficiency, found in patients with chronically severe airways obstruction, plays a role in the development of pulmonary hypertension and cor pulmonale. Patients with chronic pulmonary disease, right ventricular dilatation and concomitant arrhythmias-RBBB are at increased risk for hypornagnesemia and, therefore, Mg replacement --therapy in association with the other medication, should not be ignored.
